DSIP 2 mg (Delta Sleep-Inducing Peptide)

DSIP (Delta Sleep-Inducing Peptide) is a synthetic neuropeptide that mimics a naturally occurring peptide in the brain. It is primarily studied for its potential effects on sleep regulation, stress reduction, and neuroprotection.

How It Works

DSIP is thought to influence central nervous system activity by interacting with neurotransmitter systems involved in sleep and relaxation, including GABAergic and opioid pathways. This activity may promote deeper sleep states, reduce stress responses, and support recovery from physical and mental fatigue. It has also been explored for potential neuroprotective effects related to oxidative stress and inflammation in the brain.

Dosage Overview

DSIP is typically administered via subcutaneous injection. Commonly referenced dosing ranges from 1–2 mg per day, usually taken in the evening due to its sleep-related effects. Treatment cycles are often short, ranging from 5 to 10 days, followed by breaks to reduce tolerance development. Dosage may vary depending on individual response and intended use.

Potential Benefits

DSIP is associated with improved sleep quality, reduced anxiety, enhanced relaxation, and better stress management. It may also support recovery from physical exertion and contribute to overall cognitive well-being. Some research suggests potential neuroprotective properties, though data in humans remains limited.

Side Effects and Considerations

DSIP is generally considered well-tolerated. Possible side effects include mild drowsiness, headache, dizziness, or minor injection site irritation. These effects are typically temporary. Due to limited clinical data, careful use and monitoring are recommended when used in research or experimental contexts.